“Design, Molecular Docking, Synthesis, and Pharmacological Evaluation of Nabumetone-Derived Oxadiazole and Thiadiazole Schiff Bases as Potential EGFR Inhibitors for NSCLC”, AJPS, vol. 25, no. 5, pp. 973–991, Jan. 2026, doi: 10.32947/ajps.v25i5.1318.